Get startedLog in
    Picture of BioArctic AB logo

    BIOA B — BioArctic AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapHigh Flyer
    All News

    Brief: Bioarctic Announces Global License Agreement For Antibody Program

    Picture of BioArctic AB logoBioArctic AB
    19/12/2024 06:34
    Dec 19 (Reuters) - BioArctic AB  BIOAb.ST :
    * BIOARCTIC ANNOUNCES GLOBAL LICENSE AGREEMENT WITH BRISTOL
MYERS
SQUIBB FOR BIOARCTIC'S PYROGLUTAMATE-AMYLOID-BETA ANTIBODY
PROGRAM
    * WILL RECEIVE A USD 100 MILLION UPFRONT PAYMENT AND UP TO
USD
1.25 BILLION IN MILESTONE PAYMENTS
    * ENTITLED TO TIERED LOW DOUBLE-DIGIT ROYALTIES ON GLOBAL
PRODUCT
SALES

Source text:  ID:nWkr10ftpg 
Further company coverage:  BIOAb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on BioArctic AB

    See all news